# Planned Dosing Schedule

Update this table whenever the plan changes. Pair each update with an entry in `titration_log.md`.

| Compound | Purpose | Route | Timing | Planned dose (starting) | Frequency | Notes |
| --- | --- | --- | --- | --- | --- | --- |
| Retatrutide | Metabolic control & fat loss | SubQ | Morning or largest meal day | _e.g., X mg_ | Weekly | Start low, increase per tolerability; monitor GI, resting HR |
| Tesamorelin | GH release, visceral fat reduction | SubQ | Pre-bed | _e.g., 2 mg_ | Daily | Avoid food 1–2h pre-dose; track IGF-1 |
| CJC-1295 (no DAC) | Pulsatile GH support | SubQ | Pre-bed or split AM/PM | _e.g., 100 mcg_ | 1–2x daily | Pair with Ipamorelin for synergy |
| Ipamorelin | GH secretagogue | SubQ | Pre-bed or peri-training | _e.g., 100 mcg_ | 1–2x daily | Avoid carbs 60–90 min around dose |
| NAD+ | Mitochondrial support | IV/IM/SubQ | Morning | _e.g., 100–300 mg_ | 1–3x weekly | Titrate rate to reduce flushing |
| MOTS-c | Metabolic flexibility | SubQ | AM | _e.g., 10 mg_ | 3x weekly | Track endurance/VO2 sensations |
| SS-31 (Elamipretide) | Mitochondrial protection | SubQ | AM | _e.g., 5 mg_ | Daily | Note stamina, recovery changes |
| BPC-157 | Tissue repair, gut | SubQ (local) | AM or post-training | _e.g., 250–500 mcg_ | Daily | Target injury sites as needed |
| TB-500 | Tissue repair, mobility | SubQ | Split AM/PM | _e.g., 2–5 mg_ | Weekly loading, then maintenance | Note joint/mobility changes |
| GHK-Cu | Skin/hair support | Topical/SubQ | PM | _e.g., 2 mg_ | Daily or topical cycle | Track skin, hair density |
| KPV | Anti-inflammatory | SubQ/oral | AM | _e.g., 500 mcg_ | Daily | Watch GI symptoms |
| TRT | Foundational hormones | IM/SubQ | Per existing protocol | _e.g., 100–150 mg/wk_ | Weekly / split | Keep in therapeutic range; labs quarterly |

Add training-day vs rest-day nuances below if needed.

### Training-day adjustments (optional)
- Pre-training: _placeholder_
- Post-training: _placeholder_
- Recovery days: _placeholder_
